The Coca Leaf vs Cocaine Mistake That’s Shaping Global Drug Policy

Coca leaves and cocaine are fundamentally distinct substances, yet regulatory agencies have historically equated them, creating a major obstacle to drug policy reform. This conflation drives the prohibition of various beneficial applications for the coca plant, effectively blocking innovation and broader access to its regulated use. The persistent treatment of the raw plant as equivalent to its refined product sustains a framework that fails to recognize the actual botanical and pharmacological differences. Decoupling coca from cocaine represents a necessary step toward sensible international drug policy and the development of new, legitimate coca-based products for the global market.